BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grajales D, Ferreira V, Valverde ÁM. Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain. Cells 2019;8:E1336. [PMID: 31671770 DOI: 10.3390/cells8111336] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferreira V, Folgueira C, Guillén M, Zubiaur P, Navares M, Sarsenbayeva A, López-larrubia P, Eriksson JW, Pereira MJ, Abad-santos F, Sabio G, Rada P, Valverde ÁM. Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight. Metabolism 2022;137:155335. [DOI: 10.1016/j.metabol.2022.155335] [Reference Citation Analysis]
2 Matloka M, Janowska S, Pankiewicz P, Kokhanovska S, Kos T, Hołuj M, Rutkowska-wlodarczyk I, Abramski K, Janicka M, Jakubowski P, Świątkiewicz M, Welniak-kaminska M, Hucz-kalitowska J, Dera P, Bojarski L, Grieb P, Popik P, Wieczorek M, Pieczykolan J. A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.999685] [Reference Citation Analysis]
3 Scheen AJ, Fève B. Diabètes pharmaco-induits : quatre classes médicamenteuses au cœur de notre pratique clinique. Médecine des Maladies Métaboliques 2022;16:627-641. [DOI: 10.1016/j.mmm.2022.06.004] [Reference Citation Analysis]
4 Jiang Y, Gaur U, Cao Z, Hou S, Zheng W. Quetiapine Shortens the Lifespan of Caenorhabditis elegans through DOP-2, DAF-2 and RSKS-1. IJMS 2022;23:12927. [DOI: 10.3390/ijms232112927] [Reference Citation Analysis]
5 Piras M, Ranjbar S, Laaboub N, Grosu C, Gamma F, Plessen KJ, von Gunten A, Conus P, Eap CB. Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study. Schizophr Bull 2022:sbac133. [PMID: 36156101 DOI: 10.1093/schbul/sbac133] [Reference Citation Analysis]
6 Horska K, Ruda-Kucerova J, Skrede S. GLP-1 agonists: superior for mind and body in antipsychotic-treated patients? Trends Endocrinol Metab 2022;33:628-38. [PMID: 35902330 DOI: 10.1016/j.tem.2022.06.005] [Reference Citation Analysis]
7 Zhu Z, Gu Y, Zeng C, Yang M, Yu H, Chen H, Zhang B, Cai H. Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis. Front Pharmacol 2022;13:897926. [DOI: 10.3389/fphar.2022.897926] [Reference Citation Analysis]
8 Huang J, Chen G, Zhang Q, Wang Y, Meng Q, Xu F, Zhang X, Zou W, Mi F, Yin J. Correlation between adipocyte fatty acid binding protein and glucose dysregulation is closely associated with obesity and metabolic syndrome: A cohort of Han Chinese population from Yunnan plateau. Lipids 2022. [PMID: 35778866 DOI: 10.1002/lipd.12353] [Reference Citation Analysis]
9 Hamzehpour L, Bohn T, Jaspers L, Grimm O. Seed-based connectivity of ventral tegmental area correlates with decreased physical fitness in schizophrenia.. [DOI: 10.1101/2022.06.27.22276810] [Reference Citation Analysis]
10 Goh KK, Chen CY, Wu T, Chen C, Lu M. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. IJMS 2022;23:7092. [DOI: 10.3390/ijms23137092] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Grajales D, Vázquez P, Alén R, Hitos AB, Valverde ÁM. Attenuation of Olanzapine-Induced Endoplasmic Reticulum Stress Improves Insulin Secretion in Pancreatic Beta Cells. Metabolites 2022;12:443. [DOI: 10.3390/metabo12050443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Swathy B, Banerjee M. Understanding Pharmaco-Epigenomic Response of Antipsychotic Drugs Using Genome-Wide MicroRNA Expression Profile in Liver Cell Line. Front Mol Neurosci 2022;15:786632. [DOI: 10.3389/fnmol.2022.786632] [Reference Citation Analysis]
13 Vasileva SS, Tucker J, Siskind D, Eyles D. Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia? Expert Opin Drug Saf 2022. [PMID: 35189774 DOI: 10.1080/14740338.2022.2042251] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Fanelli G, Franke B, De Witte W, Ruisch IH, Haavik J, van Gils V, Jansen WJ, Vos SJB, Lind L, Buitelaar JK, Banaschewski T, Dalsgaard S, Serretti A, Mota NR, Poelmans G, Bralten J. Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders. Transl Psychiatry 2022;12. [DOI: 10.1038/s41398-022-01817-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Ahmadpanah M, Pezeshki R, Soltanian AR, Jahangard L, Dürsteler KM, Keshavarzi A, Brand S. Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance - Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase. J Psychiatr Res 2022;146:163-71. [PMID: 34990968 DOI: 10.1016/j.jpsychires.2021.12.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Beeler JA, Burghardt NS. The Rise and Fall of Dopamine: A Two-Stage Model of the Development and Entrenchment of Anorexia Nervosa. Front Psychiatry 2021;12:799548. [PMID: 35087433 DOI: 10.3389/fpsyt.2021.799548] [Reference Citation Analysis]
17 Kalitin KY, Spasov AA, Mukha OY, Pridvorov GV, Lipatov VA. Pharmacological Targets and Mechanisms of Action of Antipsychotic Substances in the Context of the Neurochemical Theory of the Pathogenesis of Schizophrenia. Neurosci Behav Physi 2022;52:108-123. [DOI: 10.1007/s11055-022-01213-7] [Reference Citation Analysis]
18 Bertelli MO, Azeem MW, Underwood L, Scattoni ML, Persico AM, Ricciardello A, Sappok T, Bergmann T, Keller R, Bianco A, Corti S, Miselli G, Lassi S, Croce L, Bradley E, Munir K. Autism Spectrum Disorder. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder 2022. [DOI: 10.1007/978-3-319-95720-3_16] [Reference Citation Analysis]
19 Lee SA, Cho SJ, Moon JC. The Effect of Atypical Anti-psychotic Agents on Obesity and Glucose Metabolism. J Med Life Sci 2021;18:49-55. [DOI: 10.22730/jmls.2021.18.3.49] [Reference Citation Analysis]
20 Tang C, Chua YC, Abdin E, Subramaniam M, Verma S. Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study. IJERPH 2021;19:137. [DOI: 10.3390/ijerph19010137] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Zhuo C, Xu Y, Wang H, Zhou C, Liu J, Yu X, Shao H, Tian H, Fang T, Li Q, Chen J, Xu S, Ma X, Yang W, Yao C, Li B, Yang A, Chen Y, Huang G, Lin C. Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia. J Affect Disord 2021;295:163-72. [PMID: 34464878 DOI: 10.1016/j.jad.2021.08.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zhong X, Ao Q, Xing F. Serum Levels of HCY, MIF, and hs-CRP Correlate with Glycolipid Metabolism in Adults with Never-Medicated First-Episode Schizophrenia. Evid Based Complement Alternat Med 2021;2021:7394699. [PMID: 34812265 DOI: 10.1155/2021/7394699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bellman V, Russell N, Depala K, Dellenbaugh A, Desai S, Vadukapuram R, Patel S, Srinivas S. Challenges in Treating Cancer Patients With Unstable Psychiatric Disorder. World J Oncol 2021;12:137-48. [PMID: 34804276 DOI: 10.14740/wjon1402] [Reference Citation Analysis]
24 Chen CH, Chen PY, Chen CY, Chiu CC, Lu ML, Huang MC, Lin YK, Chen YH. Associations of Genetic Variants of Methylenetetrahydrofolate Reductase and Serum Folate Levels with Metabolic Parameters in Patients with Schizophrenia. Int J Environ Res Public Health 2021;18:11333. [PMID: 34769853 DOI: 10.3390/ijerph182111333] [Reference Citation Analysis]
25 Szeliga A, Stefanowski B, Meczekalski B, Snopek M, Kostrzak A, Smolarczyk R, Bala G, Duszewska A, Smolarczyk K, Maciejewska-Jeske M. Menopause in women with schizophrenia, schizoaffective disorder and bipolar disorder. Maturitas 2021;152:57-62. [PMID: 34674808 DOI: 10.1016/j.maturitas.2021.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Zhang Y, Li X, Yao X, Yang Y, Ning X, Zhao T, Xia L, Zhang Y, Zhang K, Liu H. Do Leptin Play a Role in Metabolism-Related Psychopathological Symptoms? Front Psychiatry 2021;12:710498. [PMID: 34566714 DOI: 10.3389/fpsyt.2021.710498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Ito H, Kumagai T, Iwama T. Evaluation of an educational wellness program by sex differences in community-dwelling Japanese patients with schizophrenia. Arch Psychiatr Nurs 2021;35:450-6. [PMID: 34561058 DOI: 10.1016/j.apnu.2021.06.005] [Reference Citation Analysis]
28 Barbosa M, Fernandes V. Rapid-onset clozapine-induced hyperglycaemia: pathways of glycaemic dysregulation. BMJ Case Rep 2021;14:e243938. [PMID: 34518181 DOI: 10.1136/bcr-2021-243938] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Fenton C, Kang C. Managing glucose-related adverse events of antipsychotics is worth the effort. Drugs Ther Perspect 2021;37:415-421. [DOI: 10.1007/s40267-021-00856-9] [Reference Citation Analysis]
30 Dubath C, Piras M, Gholam M, Laaboub N, Grosu C, Sentissi O, Gamma F, Solida A, von Gunten A, Conus P, Eap CB. Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study. Pharmacopsychiatry 2021. [PMID: 34388836 DOI: 10.1055/a-1525-2820] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Speyer H, Westergaard C, Albert N, Karlsen M, Stürup AE, Nordentoft M, Krogh J. Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:577919. [PMID: 34393989 DOI: 10.3389/fendo.2021.577919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Cernea S, Dima L, Correll CU, Manu P. Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics. Drugs 2020;80:1763-81. [PMID: 32930957 DOI: 10.1007/s40265-020-01393-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 16.0] [Reference Citation Analysis]
33 Liu JH, Chen N, Guo YH, Guan XN, Wang J, Wang D, Xiu MH. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia. J Psychiatr Res 2021;140:409-15. [PMID: 34144444 DOI: 10.1016/j.jpsychires.2021.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
34 Fanelli G, Franke B, De Witte W, Ruisch IH, Haavik J, van Gils V, Jansen WJ, Vos SJB, Lind L, Buitelaar JK, Banaschewski T, Dalsgaard S, Serretti A, Mota NR, Poelmans G, Bralten J. Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders.. [DOI: 10.1101/2021.05.28.21258000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Brown JT, Campo-Soria C, Bishop JR. Current strategies for predicting side effects from second generation antipsychotics in youth. Expert Opin Drug Metab Toxicol 2021;17:655-64. [PMID: 33896324 DOI: 10.1080/17425255.2021.1922668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Libowitz MR, Nurmi EL. The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. Front Psychiatry 2021;12:623681. [PMID: 33776816 DOI: 10.3389/fpsyt.2021.623681] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
37 Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, Fasciani I, Annibale P, Maggio R, Scarselli M. Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences. Pharmaceuticals (Basel) 2021;14:238. [PMID: 33800403 DOI: 10.3390/ph14030238] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
38 Yuen JWY, Kim DD, Procyshyn RM, Panenka WJ, Honer WG, Barr AM. A Focused Review of the Metabolic Side-Effects of Clozapine. Front Endocrinol (Lausanne). 2021;12:609240. [PMID: 33716966 DOI: 10.3389/fendo.2021.609240] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
39 de Beaurepaire R. Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia: Prevalence, Antipsychotic Specificities, and Changes Over Time. J Clin Psychopharmacol 2021;41:114-20. [PMID: 33587392 DOI: 10.1097/JCP.0000000000001357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
40 Babic I, Sellers D, Else PL, Nealon J, Osborne AL, Pai N, Weston-Green K. Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats. J Psychopharmacol 2021;35:284-302. [PMID: 33570012 DOI: 10.1177/0269881120981377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Boyda HN, Procyshyn RM, Tse L, Yuen JWY, Honer WG, Barr AM. A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models. PLoS One 2021;16:e0246211. [PMID: 33508013 DOI: 10.1371/journal.pone.0246211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
42 Chen CY, Goh KK, Chen CH, Lu ML. The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia. Front Psychiatry 2020;11:605124. [PMID: 33551872 DOI: 10.3389/fpsyt.2020.605124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
43 Patel PJ, Weidenfeller C, Jones AP, Nilsson J, Hsu J. Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study. Neurol Ther 2021;10:121-47. [PMID: 33098548 DOI: 10.1007/s40120-020-00221-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Abd El-hameed AM, Eskandrani AA, Elroby FA. Assessment of the ameliorative effect of Hypericum perforatum on olanzapine-induced hepatic oxidative stress and metabolic abnormalities in experimental male albino rats. Journal of Taibah University for Science 2020;14:1496-502. [DOI: 10.1080/16583655.2020.1834757] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Namiki H. Antipsychotic pitfalls: idiopathic intracranial hypertension and antipsychotic-induced weight gain. BMJ Case Rep 2020;13:e236161. [PMID: 32606104 DOI: 10.1136/bcr-2020-236161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Sivolap Y, Portnova A. Excessive use of antipsychotics as a global problem of clinical medicine. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery) 2020. [DOI: 10.33920/med-01-2005-01] [Reference Citation Analysis]
47 Dai F, Song JH, Hong YP, Bai X, Sohn WM, Hong SJ. Dopaminergic antagonists inhibit bile chemotaxis of adult Clonorchis sinensis and its egg production. PLoS Negl Trop Dis 2020;14:e0008220. [PMID: 32226018 DOI: 10.1371/journal.pntd.0008220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]